期刊
NUTRIENTS
卷 12, 期 8, 页码 -出版社
MDPI
DOI: 10.3390/nu12082378
关键词
macroalgae; seaweed; obesity; triglyceride; adipose tissue; adipocyte
资金
- Government of the Basque Country (ELKARTEK) [KK-2019/00031]
- Instituto de Salud Carlos III (CIBERobn) [CB12/03/30007]
- University of the Basque Country [GIU18-173]
Macroalgae have attracted great interest for their potential applications in nutraceutical and pharmaceutical industries as source of bioactive medicinal products and food ingredients. This review gathers data fromin vitroandin vivostudies addressing the anti-obesity effects of macroalgae. Great consensus exists in all reportedin vitrostudies concerning the reduction induced by seaweed extracts in the expression of transcriptional factors controlling adipogenesis. In animals, macroalgae reduced body fat accumulation and prevented other obesity features, such as dyslipidemia, insulin resistance and fatty liver. These effects are not due to food intake reduction, since few studies have reported such event. Indeed, the effects on metabolic pathways in target tissues/organs seem to play a more relevant role. Macroalgae can reduce de novo lipogenesis, limiting fatty acid availability for triglyceride synthesis in white adipose tissue. This effect has been observed in both cell cultures and adipose tissue from animals treated with macroalgae extracts. In addition, increased fatty acid oxidation and thermogenic capacity, as well as a shift towards healthier gut microbiota composition may contribute to the body fat-lowering effect of macroalgae. Studies in humans are needed to determine whether macroalgae can represent a feasible tool to prevent and/or manage overweight and obesity.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据